Table 7.
Baseline characteristics for patients with SIRI, NLR, SII, Neutrophil, Monocyte and WBC (n = 255)
| Variables | SIRI | NLR | SII | Neutrophil | Monocyte | WBC |
|---|---|---|---|---|---|---|
| <1.529vs ≥1.529 | <3.441 vs ≥3.441 | <715.739 vs ≥715.739 | <2.722 vs ≥2.722 | <0.578 vs ≥0.578 | <6.177 vs ≥6.177 | |
| P | P | P | P | P | P | |
| Therapy | .759 | .208 | .277 | .120 | .603 | .126 |
| Untreated | ||||||
| Chemotherapy | ||||||
| Radiotherapy | ||||||
| Sex | .029 | .501 | .695 | .003 | .175 | .029 |
| Female | ||||||
| Male | ||||||
| Age | .010 | .093 | .054 | .064 | .120 | .433 |
| <60 | ||||||
| ≥60 | ||||||
| T | .262 | .129 | .042 | .711 | .941 | .656 |
| T1 | ||||||
| T2 | ||||||
| T3 | ||||||
| T4 | ||||||
| N | .323 | .557 | .819 | .886 | .633 | .490 |
| N0 | ||||||
| N1 | ||||||
| N2 | ||||||
| N3 | ||||||
| M | .006 | .080 | .043 | .212 | .034 | .972 |
| M0 | ||||||
| M1 | ||||||
| Histology | .681 | .440 | .317 | .155 | .316 | .799 |
| Keratinizing* | ||||||
| Non‐Keratinizing# | ||||||
| Unknown | ||||||
| SIRI | .000 | .000 | .000 | .000 | .000 | |
| <1.529 | ||||||
| ≥1.529 | ||||||
| NLR | .000 | .000 | .000 | .053 | .000 | |
| <3.441 | ||||||
| ≥3.441 | ||||||
| SII | .000 | .000 | .000 | .063 | .000 | |
| <715.739 | ||||||
| ≥715.739 | ||||||
| NEU | .000 | .000 | .000 | .000 | .000 | |
| <2.722 | ||||||
| ≥2.722 | ||||||
| MONO | .000 | .053 | .063 | .000 | .000 | |
| <0.578 | ||||||
| ≥0.578 | ||||||
| WBC | .000 | .000 | .000 | .000 | .000 | |
| <6.177 | ||||||
| ≥6.177 | ||||||
| PLT | .004 | .036 | .000 | .000 | .000 | .000 |
| <267.583 | ||||||
| ≥267.583 | ||||||
| BASO | .006 | .402 | .012 | .000 | .000 | .001 |
| <0.029 | ||||||
| ≥0.029 | ||||||
| PLR | .000 | .000 | .000 | .354 | .243 | .967 |
| <245.496 | ||||||
| ≥245.496 | ||||||
| RDW | .028 | .146 | .135 | .810 | .737 | .166 |
| <14.495 | ||||||
| ≥14.495 |